Navigating Antitrust Issues in the Life Sciences Industry

Navigating Antitrust Issues in the Life Sciences Industry

Webinar
Speaking Engagement CLE

Biotechnology, pharmaceutical, diagnostic and medical device companies at various stages often encounter potential antitrust issues arising from brand-generic competition, patent litigation and settlements, life cycle management strategies, sales practices, M&A, and other transformative transactions including licensing and competitor collaborations. In this webinar, lawyers from WilmerHale’s leading Life Sciences Practice will provide an overview of antitrust principles followed by an in-depth discussion on industry developments and considerations for in-house counsel and executives navigating these risks.

View the Webinar Recording*

*CLE credit is not available for those who watch webinar recordings.

Read More About the Event

Speakers